OriGene Technologies Buys Blue Heron
OriGene Technologies, a Rockville, Md.-based developer of monoclonal antibodies, has acquired Blue Heron Biotechnology Inc., a Bothell, Wash.-based provider of gene synthesis services. No financial terms were disclosed. OriGene has raised over $16 million in VC funding, from IDG-Accel, SBI & TH Venture Capital Enterprise, Zero2IPO, Morningside Venture Investments and President International Development Corp. Blue Heron had raised around $9 million, from Crabtree Ventures, Integra Ventures and Invitrogen Corp
16 August 2010•2 mins read
